Ondansetron orally disintegrating tablet versus placebo for the prevention of postdischarge nausea and vomiting after ambulatory surgery
- PMID: 11973189
- DOI: 10.1097/00000539-200205000-00027
Ondansetron orally disintegrating tablet versus placebo for the prevention of postdischarge nausea and vomiting after ambulatory surgery
Abstract
Ondansetron orally disintegrating tablet reduces postdischarge nausea and vomiting and improves patient satisfaction with postoperative nausea and vomiting management.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources